References

A list of the references cited in the text.

NoteHow the sources were checked
  • For all English-language papers, bibliographic details (authors, journal, volume, issue, pages, DOI, PMID) were matched against PubMed, and the claims and figures used in the text were checked against each paper’s abstract. References without an abstract (reviews, consensus statements, etc.) are cited only where the point could be confirmed from the title and bibliographic details.
  • The textbook (Pawlina and Ross 2020) is cited as the source for general descriptions of histology.
  • Some references could not be checked in full-text detail. If you cite them in lectures or papers, be sure to check the original source (via the DOI link).
Arita, Y., S. Kihara, N. Ouchi, et al. 1999. “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.” Biochemical and Biophysical Research Communications 257 (1): 79–83. https://doi.org/10.1006/bbrc.1999.0255.
Arner, E., P. O. Westermark, K. L. Spalding, et al. 2010. “Adipocyte turnover: relevance to human adipose tissue morphology.” Diabetes 59 (1): 105–9. https://doi.org/10.2337/db09-0942.
Arner, P. 2005. “Human fat cell lipolysis: biochemistry, regulation and clinical role.” Best Practice & Research. Clinical Endocrinology & Metabolism 19 (4): 471–82. https://doi.org/10.1016/j.beem.2005.07.004.
Björntorp, P. 1990. “"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.” Arteriosclerosis (Dallas, Tex.) 10 (4): 493–96.
Bujalska, I. J., S. Kumar, and P. M. Stewart. 1997. “Does central obesity reflect "Cushing’s disease of the omentum"?” Lancet (London, England) 349 (9060): 1210–13. https://doi.org/10.1016/S0140-6736(96)11222-8.
Cancello, R., J. Tordjman, C. Poitou, et al. 2006. “Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.” Diabetes 55 (6): 1554–61. https://doi.org/10.2337/db06-0133.
Chaston, T. B., and J. B. Dixon. 2008. “Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review.” International Journal of Obesity (2005) 32 (4): 619–28. https://doi.org/10.1038/sj.ijo.0803761.
Chau, Y. Y., R. Bandiera, A. Serrels, et al. 2014. “Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source.” Nature Cell Biology 16 (4): 367–75. https://doi.org/10.1038/ncb2922.
Cinti, S. 2005. “The adipose organ.” Prostaglandins, Leukotrienes, and Essential Fatty Acids 73 (1): 9–15. https://doi.org/10.1016/j.plefa.2005.04.010.
Cinti, S., G. Mitchell, G. Barbatelli, et al. 2005. “Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.” Journal of Lipid Research 46 (11): 2347–55. https://doi.org/10.1194/jlr.M500294-JLR200.
Cypess, A. M., S. Lehman, G. Williams, et al. 2009. “Identification and importance of brown adipose tissue in adult humans.” The New England Journal of Medicine 360 (15): 1509–17. https://doi.org/10.1056/NEJMoa0810780.
Eriksson-Hogling, D., D. P. Andersson, J. Bäckdahl, et al. 2015. “Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss.” International Journal of Obesity (2005) 39 (6): 893–98. https://doi.org/10.1038/ijo.2015.18.
Examination Committee of Criteria for ’Obesity Disease’ in Japan, and Japan Society for the Study of Obesity. 2002. “New criteria for ’obesity disease’ in Japan.” Circulation Journal : Official Journal of the Japanese Circulation Society 66 (11): 987–92. https://doi.org/10.1253/circj.66.987.
Fried, S. K., D. A. Bunkin, and A. S. Greenberg. 1998. “Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.” The Journal of Clinical Endocrinology and Metabolism 83 (3): 847–50. https://doi.org/10.1210/jcem.83.3.4660.
Friedman, J. M., and J. L. Halaas. 1998. “Leptin and the regulation of body weight in mammals.” Nature 395 (6704): 763–70. https://doi.org/10.1038/27376.
Garg, A. 2004. “Acquired and inherited lipodystrophies.” The New England Journal of Medicine 350 (12): 1220–34. https://doi.org/10.1056/NEJMra025261.
Gesta, S., M. Blüher, Y. Yamamoto, et al. 2006. “Evidence for a role of developmental genes in the origin of obesity and body fat distribution.” Proceedings of the National Academy of Sciences of the United States of America 103 (17): 6676–81. https://doi.org/10.1073/pnas.0601752103.
Hall, K. D. 2008. “What is the required energy deficit per unit weight loss?” International Journal of Obesity (2005) 32 (3): 573–76. https://doi.org/10.1038/sj.ijo.0803720.
Hoffstedt, J., E. Arner, H. Wahrenberg, et al. 2010. “Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity.” Diabetologia 53 (12): 2496–503. https://doi.org/10.1007/s00125-010-1889-3.
Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. “Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.” Science (New York, N.Y.) 259 (5091): 87–91. https://doi.org/10.1126/science.7678183.
Ibrahim, M. M. 2010. “Subcutaneous and visceral adipose tissue: structural and functional differences.” Obesity Reviews : An Official Journal of the International Association for the Study of Obesity 11 (1): 11–18. https://doi.org/10.1111/j.1467-789X.2009.00623.x.
Kelley, D. E., F. L. Thaete, F. Troost, T. Huwe, and B. H. Goodpaster. 2000. “Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.” American Journal of Physiology. Endocrinology and Metabolism 278 (5): E941–8. https://doi.org/10.1152/ajpendo.2000.278.5.E941.
Knittle, J. L., K. Timmers, F. Ginsberg-Fellner, R. E. Brown, and D. P. Katz. 1979. “The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size.” The Journal of Clinical Investigation 63 (2): 239–46. https://doi.org/10.1172/JCI109295.
Kuk, J. L., T. J. Saunders, L. E. Davidson, and R. Ross. 2009. “Age-related changes in total and regional fat distribution.” Ageing Research Reviews 8 (4): 339–48. https://doi.org/10.1016/j.arr.2009.06.001.
Lee, M. J., Y. Wu, and S. K. Fried. 2013. “Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.” Molecular Aspects of Medicine 34 (1): 1–11. https://doi.org/10.1016/j.mam.2012.10.001.
Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).” The Journal of Biological Chemistry 270 (22): 12953–56. https://doi.org/10.1074/jbc.270.22.12953.
Loke, Y. K., S. Singh, and C. D. Furberg. 2009. “Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.” CMAJ : Canadian Medical Association Journal = Journal de l’Association Medicale Canadienne 180 (1): 32–39. https://doi.org/10.1503/cmaj.080486.
Lovejoy, J. C., C. M. Champagne, L. de Jonge, H. Xie, and S. R. Smith. 2008. “Increased visceral fat and decreased energy expenditure during the menopausal transition.” International Journal of Obesity (2005) 32 (6): 949–58. https://doi.org/10.1038/ijo.2008.25.
Maeda, K., K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara. 1996. “cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).” Biochemical and Biophysical Research Communications 221 (2): 286–89. https://doi.org/10.1006/bbrc.1996.0587.
Manolopoulos, K. N., F. Karpe, and K. N. Frayn. 2010. “Gluteofemoral body fat as a determinant of metabolic health.” International Journal of Obesity (2005) 34 (6): 949–59. https://doi.org/10.1038/ijo.2009.286.
Mehlem, A., C. E. Hagberg, L. Muhl, U. Eriksson, and A. Falkevall. 2013. “Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease.” Nature Protocols 8 (6): 1149–54. https://doi.org/10.1038/nprot.2013.055.
Meza-Perez, S., and T. D. Randall. 2017. “Immunological Functions of the Omentum.” Trends in Immunology 38 (7): 526–36. https://doi.org/10.1016/j.it.2017.03.002.
Miyazaki, Y., A. Mahankali, M. Matsuda, et al. 2002. “Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.” The Journal of Clinical Endocrinology and Metabolism 87 (6): 2784–91. https://doi.org/10.1210/jcem.87.6.8567.
Nesto, R. W., D. Bell, R. O. Bonow, et al. 2003. “Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.” Circulation 108 (23): 2941–48. https://doi.org/10.1161/01.CIR.0000103683.99399.7E.
Nielsen, S., Z. Guo, C. M. Johnson, D. D. Hensrud, and M. D. Jensen. 2004. “Splanchnic lipolysis in human obesity.” The Journal of Clinical Investigation 113 (11): 1582–88. https://doi.org/10.1172/JCI21047.
Oral, E. A., V. Simha, E. Ruiz, et al. 2002. “Leptin-replacement therapy for lipodystrophy.” The New England Journal of Medicine 346 (8): 570–78. https://doi.org/10.1056/NEJMoa012437.
Ouchi, N., S. Kihara, Y. Arita, et al. 1999. “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.” Circulation 100 (25): 2473–76. https://doi.org/10.1161/01.cir.100.25.2473.
Pawlina, W., and M. H. Ross. 2020. Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. 8th ed. Wolters Kluwer.
Rosen, E. D., and B. M. Spiegelman. 2014. “What we talk about when we talk about fat.” Cell 156 (1-2): 20–44. https://doi.org/10.1016/j.cell.2013.12.012.
Ryo, M., T. Nakamura, S. Kihara, et al. 2004. “Adiponectin as a biomarker of the metabolic syndrome.” Circulation Journal : Official Journal of the Japanese Circulation Society 68 (11): 975–81. https://doi.org/10.1253/circj.68.975.
Scherer, P. E., S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish. 1995. “A novel serum protein similar to C1q, produced exclusively in adipocytes.” The Journal of Biological Chemistry 270 (45): 26746–49. https://doi.org/10.1074/jbc.270.45.26746.
Shimomura, I., T. Funahashi, M. Takahashi, et al. 1996. “Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.” Nature Medicine 2 (7): 800–803. https://doi.org/10.1038/nm0796-800.
Spalding, K. L., E. Arner, P. O. Westermark, et al. 2008. “Dynamics of fat cell turnover in humans.” Nature 453 (7196): 783–87. https://doi.org/10.1038/nature06902.
Stenkula, K. G., and C. Erlanson-Albertsson. 2018. “Adipose cell size: importance in health and disease.” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 315 (2): R284–95. https://doi.org/10.1152/ajpregu.00257.2017.
Sun, K., C. M. Kusminski, and P. E. Scherer. 2011. “Adipose tissue remodeling and obesity.” The Journal of Clinical Investigation 121 (6): 2094–101. https://doi.org/10.1172/JCI45887.
Tchkonia, T., D. E. Morbeck, T. Von Zglinicki, et al. 2010. “Fat tissue, aging, and cellular senescence.” Aging Cell 9 (5): 667–84. https://doi.org/10.1111/j.1474-9726.2010.00608.x.
Tchkonia, T., Y. D. Tchoukalova, N. Giorgadze, et al. 2005. “Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.” American Journal of Physiology. Endocrinology and Metabolism 288 (1): E267–77. https://doi.org/10.1152/ajpendo.00265.2004.
Tchkonia, T., T. Thomou, Y. Zhu, et al. 2013. “Mechanisms and metabolic implications of regional differences among fat depots.” Cell Metabolism 17 (5): 644–56. https://doi.org/10.1016/j.cmet.2013.03.008.
Van Harmelen, V., S. Reynisdottir, P. Eriksson, et al. 1998. “Leptin secretion from subcutaneous and visceral adipose tissue in women.” Diabetes 47 (6): 913–17. https://doi.org/10.2337/diabetes.47.6.913.
Virtue, S., and A. Vidal-Puig. 2010. “Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome–an allostatic perspective.” Biochimica Et Biophysica Acta 1801 (3): 338–49. https://doi.org/10.1016/j.bbalip.2009.12.006.
Wajchenberg, B. L. 2000. “Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.” Endocrine Reviews 21 (6): 697–738. https://doi.org/10.1210/edrv.21.6.0415.
Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and Ferrante AW Jr. 2003. “Obesity is associated with macrophage accumulation in adipose tissue.” The Journal of Clinical Investigation 112 (12): 1796–808. https://doi.org/10.1172/JCI19246.
Weyer, C., J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley. 2000. “Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.” Diabetologia 43 (12): 1498–506. https://doi.org/10.1007/s001250051560.
WHO Expert Consultation. 2004. “Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.” Lancet (London, England) 363 (9403): 157–63. https://doi.org/10.1016/S0140-6736(03)15268-3.
Wu, J., P. Boström, L. M. Sparks, et al. 2012. “Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human.” Cell 150 (2): 366–76. https://doi.org/10.1016/j.cell.2012.05.016.
Yamauchi, T., J. Kamon, H. Waki, et al. 2001. “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.” Nature Medicine 7 (8): 941–46. https://doi.org/10.1038/90984.
菅波孝祥. 2024. “加齢による皮下脂肪萎縮の分子基盤の解明.” コスメトロジー研究報告(コーセーコスメトロジー研究財団) 32: 109–13. https://www.kose-cosmetology.or.jp/research_report/archives/2024/fullVersion/Cosmetology_Vol32_2024_p109-113_Takayoshi_Suganuma.pdf.